Anavex Life Sciences Corporation (NASDAQ:AVXL) price on current trading day, rose 14.74% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $8.72.
A look at the stock’s price movement, the close in the last trading session was $7.60, moving within a range at $7.265 and $8.72. The beta value (5-Year monthly) was 0.801. Turning to its 52-week performance, $14.44 and $3.25 were the 52-week high and 52-week low respectively. Overall, AVXL moved -2.90% over the past month.
Anavex Life Sciences Corporation’s market cap currently stands at around $741.76 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-11.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AVXL is a Hold. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
6 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 4 recommend AVXL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AVXL’s current price about -2.86% and -0.59% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 49.53, while 7-day volatility ratio is 12.62% and 8.11% in the 30-day chart. Further, Anavex Life Sciences Corporation (AVXL) has a beta value of 0.88, and an average true range (ATR) of 0.75. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $11 and high of $11. Looking at the price targets, the low is -26.15% off current price level while to achieve the yearly target high, price needs to move -26.15%. Nonetheless, investors will most likely welcome a -26.15% jump to $11 which is the analysts’ median price.
If we refocus on Anavex Life Sciences Corporation (NASDAQ:AVXL), historical trading data shows that trading volumes averaged 1.54 over the past 10 days and 1.22 million over the past 3 months. The company’s latest data on shares outstanding shows there are 84.99 million shares.
The 3.30% of Anavex Life Sciences Corporation’s shares are in the hands of company insiders while institutional holders own 34.47% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 24.04 million on 2025-03-14, giving us a short ratio of 24.01. The data shows that as of 2025-03-14 short interest in Anavex Life Sciences Corporation (AVXL) stood at 2915.0 of shares outstanding, with shares short falling to 24.2 million registered in 2025-02-14. Current price change has pushed the stock -18.81% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AVXL stock continues to rise going into the next quarter.
